|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2006
doi: 10.1183/09031936.06.00076405
Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy
1 Servei de Pneumologia, Hospital General Vall d'Hebron, and 2 Laboratori de Bioestadística i Epidemiologia, Universtitat Autònoma de Barcelona, Barcelona, Spain.
CORRESPONDENCE: J. Ferrer, Servei de Pneumologia, Hospital General Vall d'Hebron, Passeig Vall d'Hebron, 119-129, 08035 Barcelona, Spain. Fax: 34 932746083. E-mail: jjferrer{at}vhebron.net
Keywords: Chronic obstructive pulmonary disease, comorbidity, mortality, oxygen inhalation therapy, weight loss
Received: June 30, 2005
Accepted December 12, 2005
The aim of this study was to investigate the association between clinical variables and all-cause and respiratory mortality in patients with chronic obstructive pulmonary disease (COPD) undergoing long-term oxygen therapy (LTOT).
The authors retrospectively studied a historic cohort of 128 patients with COPD (126 males, mean age±SD 68.9±9.7 yrs, body mass index (BMI) 25.1±4.5 kg·m–2, and forced expiratory volume in one second 25.4±8.8% predicted), who were being treated with long-term oxygen therapy in a tertiary teaching hospital between 1992 and 1999. Comorbidity, assessed with the Charlson Index, was present in 38% of the patients. Vital status and cause of death were assessed through the population death registry.
A total of 78 patients (61%) had died by the end of follow-up. Three-year survival was 55%. Death was due to respiratory causes in 77% of cases. On Cox analysis, BMI <25 kg·m–2, comorbid conditions, age
In conclusion, body mass index <25 kg·m–2 and comorbidity were predictors of all-cause and respiratory mortality in a cohort of chronic obstructive pulmonary disease patients treated with long-term oxygen therapy. These factors should be taken into account when considering the management and prognosis of these patients.
70 yrs and cor pulmonale were associated with all-cause mortality. The BMI and comorbidity were the only significant predictive factors when the analysis was restricted to respiratory mortality.
This article has been cited by other articles:
|
|
 |
|
  M-C. L. Machado, W. M. Vollmer, S. M. Togeiro, A. L. Bilderback, M-V. C. Oliveira, F. S. Leitao, F. Queiroga Jr, G. Lorenzi-Filho, and J. A. Krishnan CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Eur. Respir. J., January 1, 2010; 35(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Testa, F. Cacciatore, G. Galizia, D. Della-Morte, F. Mazzella, S. Russo, N. Ferrara, F. Rengo, and P. Abete Charlson Comorbidity Index does not predict long-term mortality in elderly subjects with chronic heart failure Age Ageing, November 1, 2009; 38(6): 734 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Munoz, F. Torres, G. Sampol, J. Rios, S. Marti, and E. Escrich Accuracy and reliability of pulse oximetry at different arterial carbon dioxide pressure levels Eur. Respir. J., October 1, 2008; 32(4): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Crisafulli, S Costi, F Luppi, G Cirelli, C Cilione, O Coletti, L M Fabbri, and E M Clini Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation Thorax, June 1, 2008; 63(6): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Makita, Y. Nasuhara, K. Nagai, Y. Ito, M. Hasegawa, T. Betsuyaku, Y. Onodera, N. Hizawa, M. Nishimura, and the Hokkaido COPD Cohort Study Group Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease Thorax, November 1, 2007; 62(11): 932 - 937. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |